Risedronate sodium (also known as risedronic acid) is a bisphosphonate medication used to treat and prevent bone-related conditions. It works by inhibiting osteoclast activity, thereby slowing the breakdown of bone and helping to maintain or increase bone density.
Risedronate is commonly prescribed to:
∙ Prevent and treat osteoporosis in postmenopausal women and men
∙ Treat glucocorticoid-induced osteoporosis
∙ Treat Paget’s disease of bone, which involves abnormal bone destruction and regrowth
It is typically taken orally in tablet form, either daily, weekly, or monthly, depending on the condition being treated.

Parent: Risedronate Sodium

Parent: Risedronate Sodium

Parent: Risedronate Sodium
Impurities in Risedronate sodium may develop during synthesis, formulation, or storage, and must be carefully controlled per ICH and regulatory standards to ensure product safety and efficacy.
Process-Related Impurities
Degradation Impurities
Elemental Impurities
Analytical Techniques for Impurity Detection
Risedronate sodium is used to:
Common side effects include:
Less common but serious side effects: